{"altmetric_id":507413,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["JHypertension"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5e93cf058f610005a49","doi":"10.1097\/01.hjh.0000379530.43960.ec","first_seen_on":"2011-12-25T18:47:38+00:00","issns":["0263-6352"],"issue":"","journal":"Journal of Hypertension","last_mentioned_on":1324838430,"links":["http:\/\/journals.lww.com\/jhypertension\/Fulltext\/2010\/06001\/The_New_Angiotensin_Receptor_Blocker_Azilsartan.1273.aspx?utm_source=twitterfeed&utm_medium=twitter"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/jhypertension\/2010\/06001\/The_New_Angiotensin_Receptor_Blocker_Azilsartan.1273.pdf","pubdate":"2010-06-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"e442","title":"THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL HAS SIGNIFICANTLY GREATER 24-HOUR BLOOD PRESSURE LOWERING EFFICACY TO BOTH OLMESARTAN AND VALSARTAN: 9D.05","type":"article","volume":"28","mendeley_url":"http:\/\/www.mendeley.com\/research\/new-angiotensin-receptor-blocker-azilsartan-medoxomil-significantly-greater-24hour-blood-pressure-lo"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4506214,"mean":5.1186469373082,"rank":3108013,"this_scored_higher_than_pct":22,"this_scored_higher_than":994284,"rank_type":"exact","sample_size":4506214,"percentile":22},"similar_age_3m":{"total_number_of_other_articles":235302,"mean":4.1834003425402,"rank":147505,"this_scored_higher_than_pct":23,"this_scored_higher_than":56162,"rank_type":"exact","sample_size":235302,"percentile":23},"this_journal":{"total_number_of_other_articles":1756,"mean":2.0189116809117,"rank":1034,"this_scored_higher_than_pct":13,"this_scored_higher_than":231,"rank_type":"exact","sample_size":1756,"percentile":13},"similar_age_this_journal_3m":{"total_number_of_other_articles":69,"mean":1.0147058823529,"rank":37,"this_scored_higher_than_pct":2,"this_scored_higher_than":2,"rank_type":"exact","sample_size":69,"percentile":2}}},"demographics":{"poster_types":{"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":[],"by_discipline":[]}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/JHypertension\/status\/151009438998867969","citation_ids":[507413],"posted_on":"2011-12-25T18:40:30+00:00","author":{"name":"J Hypertension","url":"http:\/\/www.jhypertension.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1694937141\/HJH_cover_square_normal.jpg","description":"The Journal contains primary papers from world-renowned experts and authoritative reviews that summarize and evaluate the most significant recent developments.","id_on_source":"JHypertension","tweeter_id":"437628033","geo":{"lt":null,"ln":null},"followers":989},"tweet_id":"151009438998867969"}]}}